Association of inflammatory markers based on routine blood with prognosis in patients underwent percutaneous coronary

Li Kun Huo1,2, Kang Yin Chen1, Gary Tse1,3,4

  • 1Department of Cardiology, Tianjin Key Laboratory of Ions and Molecular Function of Cardiovascular Diseases, The Second Hospital of Tianjin Medical University, Tianjin Institute of Cardiology, Tianjin, China.

Medicine
|May 10, 2024
PubMed

Insights

Inflammation markers, including neutrophil-to-lymphocyte ratio (NLR) and red cell distribution width (RDW), predict 1-year mortality after percutaneous coronary intervention (PCI). Higher NLR and RDW levels are associated with increased risk, improving patient risk stratification.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Biomarker Analysis

Background:

  • Inflammation is a key factor in coronary artery disease (CAD) progression.
  • Percutaneous coronary intervention (PCI) is a common treatment for CAD.
  • Predicting mortality after PCI is crucial for patient management.

Purpose of the Study:

  • To investigate the association between inflammatory biomarkers and 1-year all-cause mortality in patients undergoing PCI.
  • To evaluate the predictive value of neutrophil-to-lymphocyte ratio (NLR) and red cell distribution width (RDW) for mortality after PCI.

Main Methods:

  • Retrospective cohort study of 4651 patients who underwent PCI.
  • Analysis of baseline demographic, clinical, and laboratory parameters.
  • Cox regression, restricted cubic spline, and ROC analyses were used to assess the association between biomarkers and mortality.

Main Results:

  • 198 (4.26%) patients died within 1 year post-PCI.
  • NLR and RDW were significant independent predictors of 1-year all-cause mortality after adjusting for confounders.
  • Multivariable models incorporating NLR and RDW improved the area under the curve to 0.83 for mortality prediction.

Conclusions:

  • NLR and RDW are valuable inflammatory biomarkers for predicting 1-year mortality in patients after PCI.
  • These biomarkers can enhance risk stratification and inform clinical decision-making.
  • A nomogram was developed for predicting individual mortality risk.